Drug Channels Archive for October, 2022


Click a link below to view the mailing archive as if it had been sent to you.

2022-10-28 07:46Drug Channels - How the Therapy Warranty Model Shifts the Paradigm of Therapy Success
2022-10-25 07:56Drug Channels News Roundup, October 2022: Mark Cuban on PBMs, Walgreens & 340B, Biosimilar Boom Update, Physicians vs. UM, and Wellness at Walgreens
2022-10-21 07:56Drug Channels - Innovation Brings Unwavering Patient Support in a New Era of Specialty Medicine
2022-10-18 07:46Drug Channels - How the Biosimilar Boom Boosts Drug Wholesalers' Profits
2022-10-17 08:59Drug Channels - Informa Connect's Trade & Channel Strategies Summit
2022-10-17 07:46Drug Channels - Informa Connect's Trade & Channel Strategies Summit
2022-10-14 07:56Drug Channels - What Pharma Companies Can Expect From the Influx of Humira Biosimilars
2022-10-13 07:55Drug Channels - Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A 2022 Update
2022-10-11 07:50Drug Channels - NEW: The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
2022-10-07 07:56Drug Channels - vitaCare From GoodRx Reimagines Prescription Services for a Wider Range of Patients and Treatments Than Traditional Hub Services (Guest Post)
2022-10-04 07:46Drug Channels - Five Surprising Facts About GoodRx and the Discount Card Market

 

<< Archive IndexSubscribe >>